Literature DB >> 22765894

The design, synthesis, and biological evaluation of potent receptor tyrosine kinase inhibitors.

Moon H Kim1, Amy Lew Tsuhako, Erick W Co, Dana T Aftab, Frauke Bentzien, Jason Chen, Wei Cheng, Stefan Engst, Levina Goon, Rhett R Klein, Donna T Le, Morrison Mac, Jason J Parks, Fawn Qian, Monica Rodriquez, Thomas J Stout, Jeffrey H Till, Kwang-Ai Won, Xiang Wu, F Michael Yakes, Peiwen Yu, Wentao Zhang, Yeping Zhao, Peter Lamb, John M Nuss, Wei Xu.   

Abstract

Variously substituted indolin-2-ones were synthesized and evaluated for activity against KDR, Flt-1, FGFR-1 and PDGFR. Extension at the 5-position of the oxindole ring with ethyl piperidine (compound 7i) proved to be the most beneficial for attaining both biochemical and cellular potencies. Further optimization of 7i to balance biochemical and cellular potencies with favorable ADME/ PK properties led to the identification of 8h, a compound with a clean CYP profile, acceptable pharmacokinetic and toxicity profiles, and robust efficacy in multiple xenograft tumor models.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22765894     DOI: 10.1016/j.bmcl.2012.06.029

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  3 in total

1.  StructMAn: annotation of single-nucleotide polymorphisms in the structural context.

Authors:  Alexander Gress; Vasily Ramensky; Joachim Büch; Andreas Keller; Olga V Kalinina
Journal:  Nucleic Acids Res       Date:  2016-05-05       Impact factor: 16.971

2.  Dual inhibitors of hepatitis C virus and hepatocellular carcinoma: design, synthesis and docking studies.

Authors:  Mostafa Mm El-Miligy; Samia M Rida; Fawzia A Ashour; Mona H Badr; Ehab M El-Bassiony; Maha A El-Demellawy; Ashraf M Omar
Journal:  Future Sci OA       Date:  2017-10-25

3.  Design, synthesis and biological evaluation of novel bromophenol derivatives incorporating indolin-2-one moiety as potential anticancer agents.

Authors:  Li-Jun Wang; Shuai-Yu Wang; Bo Jiang; Ning Wu; Xiang-Qian Li; Bao-Cheng Wang; Jiao Luo; Meng Yang; Shui-Hua Jin; Da-Yong Shi
Journal:  Mar Drugs       Date:  2015-02-02       Impact factor: 5.118

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.